Determinants of Left Ventricular Hypertrophy and Systolic Dysfunction in Chronic Renal Failure

American Journal of Kidney Diseases

Volumn 24, Issue 5, 1994, Pages 768-776

  Greaves, Sally C ^a   Gamble, Greg D ^a   Collins, John F ^a   Whalley, Gillian A ^a   Sharpe, D Norman ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

dialysis; echocardiography; left ventricular function; Uremia

Indexed keywords

ALKALINE PHOSPHATASE; PARATHYROID HORMONE;

ADULT; AGE; AGED; ANEMIA; ARTICLE; CHRONIC KIDNEY FAILURE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE WALL; HEMATOCRIT; HEMODIALYSIS; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; M MODE ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SECONDARY HYPERPARATHYROIDISM; SYSTOLIC BLOOD PRESSURE; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 0027949369     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(12)80670-6     Document Type: Article

References (33)

1. Congestive heart failure in dialysis patients
2. Cardiac abnormalities and exercise tolerance in patients receiving renal replacement therapy
3. Uremic cardiomyopathy: An inadequate left ventricular hypertrophy
4. Secondary hyperparathyroidism and cardiac hypertrophy in hemodialysis patients
5. Left ventricular hypertrophy in end-stage renal disease
6. Role of anemia in the pathogenesis of left ventricular hypertrophy in end-stage renal disease
7. Regression of left ventricular hypertrophy in dialysis patients following correction of anemia with recombinant human erythropoietin
8. Association between aluminum accumulation and cardiac hypertrophy in hemodialyzed patients
9. Smoking, hypertension and mortality in a maintenance dialysis population
10. Low-output left ventricular failure in endstage renal disease
11. Outcome of congestive heart failure, dilated cardiomyopathy, hypertrophy hyperkinetic disease, and ischemic heart disease in dialysis patients
12. Impact of left ventricular hypertrophy on survival in endstage renal disease
13. Predicting survival in adults with end-stage renal disease: An age equivalence index
14. The clinical course of left ventricular hypertrophy in dialysis patients
15. Committee on M-mode standardisation of the American Society of Echocardiography. Recommendations regarding quantification in M-mode echocardiography: Results of a survey of echocardiographic measurements
16. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings
17. Left ventricular wall thickness and plasma catecholamines in borderline and stable essential hypertension
18. Regression of left ventricular hypertrophy: Partial answers for persistent questions
19. Diabetes and cardiovascular disease
20. Left ventricular function in diabetes mellitus I
21. Left ventricular function in diabetes mellitus II
22. Echocardiographic-determined left ventricular wall characteristics in insulin dependent diabetic patients
23. Hypertension and cardiovascular risk factors in hemodialyzed diabetic patients
24. Vascular changes in hemodialysis patients in response to recombinant human erythropoietin
25. Beneficial effects of erythropoietin on hematological parameters, aerobic capacity and body fluid composition in patients on hemodialysis
26. Long-term cardiorespiratory effects of amelioration of renal anemia by erythropoietin
27. Disabling angina pectoris with normal coronary arteries in patients undergoing longterm hemodialysis
28. Dialysis-associated ischemic heart disease: Insights from coronary arteriography
29. Cardiovascular changes in chronic hemodialysis patients
30. Echocardiographic assessment of a normal adult aging population